Global Newborn Screening Instruments Market Growth 2023-2029

Global Newborn Screening Instruments Market Growth 2023-2029

Product Code:457282

Published Date: Apr 25,2023

Pages: 109

Region: Global

Category: Medical Devices & Consumables

PDF DOWNLOAD

GET FREE SAMPLE

CUSTOMIZE REQUEST

PDF DOWNLOAD

GET FREE SAMPLE

CUSTOMIZE REQUEST

SELECT A FORMAT

ADD TO BASKET

BUY NOW

Provide comprehensive and accurate analysis and reports according to your exact requirements

Provide comprehensive and accurate analysis and reports according to your exact requirements

CONTACT US

The global Newborn Screening Instruments market size is projected to grow from US$ 457.7 million in 2022 to US$ 761.4 million in 2029; it is expected to grow at a CAGR of 7.5% from 2023 to 2029.

The key manufacturers of newborn screening instruments worldwide are Perkinelmer, Waters, Natus Medical, Danaher, Thermo Fisher, Trivitron Healthcare, Agilent Technologies, and others. The top four manufacturers together hold 50% of the market share, with Perkinelmer being the largest manufacturer with 30%. The global origin is mainly distributed in North America, Europe, India, etc. North America is the largest market with a market share of 32%, followed by Europe and Asia Pacific. In terms of product categories, blood screening account for the major share with 75%, followed by hearing screening and pulse oximeteris with 15% and 10% shares. In terms of applications, hospitals are the top application area with a 60% share, followed by independent laboratories with a 35% share.

Newborn screening is the practice of testing every newborn harmful or potentially fatal disorder that is not otherwise apparent at birth.

Newborn screening identifies conditions that can affect a child’s long-term health or survival. This screening technology includes a series of tests essential for timely detection, early diagnosis, and health management to prevent overall disability and avert death of a child. These tests are performed shortly after the baby is born, and detect genetic, developmental, and metabolic disorders in newborn babies and are tested for hearing loss and critical congenital heart defects (CCHDs) prior to discharge from a hospital or birthing center.

In this report, we study the instruments used in newborn screening.

LPI (LP Information)' newest research report, the “Newborn Screening Instruments Industry Forecast” looks at past sales and reviews total world Newborn Screening Instruments sales in 2022, providing a comprehensive analysis by region and market sector of projected Newborn Screening Instruments sales for 2023 through 2029. With Newborn Screening Instruments sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Newborn Screening Instruments industry.

This Insight Report provides a comprehensive analysis of the global Newborn Screening Instruments landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Newborn Screening Instruments portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Newborn Screening Instruments market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Newborn Screening Instruments and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Newborn Screening Instruments.

This report presents a comprehensive overview, market shares, and growth opportunities of Newborn Screening Instruments market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:
Segmentation by type
    Blood Screening
    Hearing Screening
    Pulse Oximetry

Segmentation by application
    Hospital
    Independent Laboratories
    Other

This report also splits the market by region:
    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
    Perkinelmer
    Waters
    Natus Medical
    Danaher
    Thermo Fisher
    Trivitron Healthcare
    Agilent Technologies
    Bio-Rad Laboratories
    Medtronic
    Masimo

Key Questions Addressed in this Report
What is the 10-year outlook for the global Newborn Screening Instruments market?
What factors are driving Newborn Screening Instruments market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Newborn Screening Instruments market opportunities vary by end market size?
How does Newborn Screening Instruments break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?